CD2
T-cell surface antigen CD2
Also known as: CD2_HUMAN, SRBC
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P06729
- Gene
- CD2
- Ensembl
- ENSG00000116824
- Chromosome
- 1
- Canonical length
- 351 aa
- Protein class
- CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus,Plasma membrane
OverviewNCBI Gene
The protein encoded by this gene is a surface antigen found on all peripheral blood T-cells. The encoded protein interacts with LFA3 (CD58) on antigen presenting cells to optimize immune recognition. A locus control region (LCR) has been found in the 3' flanking sequence of this gene. [provided by RefSeq, Jun 2016]
Canonical amino-acid sequenceUniProt
351 residues, UniProt reviewed canonical sequence.
>P06729|CD2
1 MSFPCKFVAS FLLIFNVSSK GAVSKEITNA LETWGALGQD INLDIPSFQM SDDIDDIKWE
61 KTSDKKKIAQ FRKEKETFKE KDTYKLFKNG TLKIKHLKTD DQDIYKVSIY DTKGKNVLEK
121 IFDLKIQERV SKPKISWTCI NTTLTCEVMN GTDPELNLYQ DGKHLKLSQR VITHKWTTSL
181 SAKFKCTAGN KVSKESSVEP VSCPEKGLDI YLIIGICGGG SLLMVFVALL VFYITKRKKQ
241 RSRRNDEELE TRAHRVATEE RGRKPHQIPA STPQNPATSQ HPPPPPGHRS QAPSHRPPPP
301 GHRVQHQPQK RPPAPSGTQV HQQKGPPLPR PRVQPKPPHG AAENSLSPSS NLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CD2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 233 nTPM
Expression across tissuesHPA
Tissue
- thymus: 233 nTPM
- lymph node: 112 nTPM
- tonsil: 74 nTPM
- appendix: 48 nTPM
- spleen: 42 nTPM
- small intestine: 27 nTPM
Single-cell type
- t-cells: 525 nCPM
- nk-cells: 142 nCPM
- innate lymphoid cells: 132 nCPM
- thymocytes: 42 nCPM
- cdc: 31 nCPM
- late primary spermatocytes: 22 nCPM
Immune cell
- NK-cell: 1,111 nTPM
- memory CD8 T-cell: 714 nTPM
- T-reg: 657 nTPM
- memory CD4 T-cell: 612 nTPM
- total PBMC: 565 nTPM
- naive CD8 T-cell: 488 nTPM
Brain region
- medulla oblongata: 2.3 nTPM
- white matter: 1.5 nTPM
- thalamus: 1.3 nTPM
- spinal cord: 1.2 nTPM
- pons: 1.1 nTPM
- choroid plexus: 1 nTPM
ReferencesPubMed · IEDB
Publications for CD2 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
5 publications
- Distinct regulatory roles of lymphocyte costimulatory pathways on T helper type-2 mediated autoimmune disease.
1996 · J Exp Med · RCR 1.1 · 54 citations - Reconstitution of peripheral blood lymphocyte subsets in the long-term disease-free survivors of patients with acute myeloblastic leukemia.
1998 · Leukemia · RCR 0.6 · 24 citations - The interferon-inducible Staf50 gene is downregulated during T cell costimulation by CD2 and CD28.
2000 · J Interferon Cytokine Res · RCR 0.5 · 31 citations - Anti-CD3 and anti-CD2-induced T-cell activation in primary Sjögren's syndrome.
1989 · Clin Exp Rheumatol · RCR 0.1 · 3 citations - A human monoclonal antibody to a human self-antigen, CD2 derived from human peripheral blood lymphocytes engrafted in SCID mice.
1995 · Hybridoma · RCR 0.1 · 3 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.62
- gnomAD pLI
- 0.47
- gnomAD missense Z
- 0.07
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- cell surface receptor signaling pathway
- cell-cell adhesion
- heterotypic cell-cell adhesion
- immune response
- membrane raft polarization
- natural killer cell activation
- natural killer cell mediated cytotoxicity
- positive regulation of interleukin-8 production
- positive regulation of myeloid dendritic cell activation
- positive regulation of tumor necrosis factor production
- positive regulation of type II interferon production
- regulation of T cell differentiation
- T cell activation
Molecular functions
- identical protein binding
- receptor tyrosine kinase binding
- signaling receptor activity
- signaling receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CD2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CD2 as an antibody target. Whether an autoantibody or antibody against CD2 could matter depends on whether native CD2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CD2 is annotated at the cell surface, where native CD2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CD2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...